This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

About ATTR-CMAbout

Learn about ATTR-CM and uncover the differences between hereditary and wild-type ATTR-CM

Types of ATTR-CM

Menu

Close

Suspect ATTR-CMDetect ATTR-CMSupporting ResourcesTreatment Option

Click here for Vyndaqel®▼ (tafamidis) Prescribing Information.

Supporting resources Dr Ana Martinez-Naharro (National Amyloidosis Centre & Royal Free Hospital, London)

Importance of nuclear medicine for early diagnosis of ATTR-CM

Summary of Ana Martinez-Naharro's presentation at the RCR Annual Conference 2023 highlighting the importance of nuclear medicine for early diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM).

Dr Nigel Lewis (Sheffield Teaching Hospitals, Sheffield)

Red Flags of ATTR-CM

Summary of Nigel Lewis' presentation at the BCS Symposium 2021 highlighting the red flags for ATTR-CM including the cardiac and non-cardiac manifestations.

Dr Kate Gatenby (Leeds General Infirmary, Leeds)

Diagnosis of ATTR-CM

Summary of Kate Gatenby's presentation at the BCS Symposium 2021 highlighting the characteristic findings on imaging that would point to a diagnosis of ATTR-CM.

Dr Will Moody (Queen Elizabeth Hospital, Birmingham)

Management of ATTR-CM

Summary of Will Moody's presentation at the BCS Symposium 2021, discussing a case study of a patient diagnosed with ATTR-CM.

Dr Lisa Anderson (St George's Hospital, London) ​​​​​

Tips for Detecting Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Summary video from the 2020 BSH Congress Symposium with Lisa Anderson, who shares some important tips for helping you to detect TTR cardiac amyloidosis, including example criteria of a patients history.

Expert Videos
Building the knowledge: Biological foundations of ATTR amyloidosis

This module reviews the biological foundation and disease mechanism of ATTR amyloidosis.

Building the knowledge: One disease with many faces

​​​​​​​This video breaks down the various types of ATTR amyloidosis and the clinical clues that can raise suspicion of ATTR-CM.

Building the knowledge: ​​​​​​​The patient journey to diagnosis of ATTR-CM, a race against time

This module reviews the importance of an early diagnosis of ATTR-CM.

Building the knowledge: Appropriately diagnosing ATTR-CM

The last in the series video reviews non-invasive and invasive approaches for the diagnosis of ATTR-CM.

Building the Knowledge
Downloadable ResourcesRed flags leave piece that looks at ATTR-CM, the signs to suspect ATTR-CM and the tools that help diagnose ATTR-CM.DownloadLoadingOn-Demand Congresses BCS 2021- British Cardiovascular Society:

Dr Nigel Lewis (Northern General Hospital, Sheffield
Dr Kate Gatenby (Leeds General Infirmary, Leeds
Dr William Moody (Queen Elizabeth Hospital, Birmingham & the Midlands Amyloid Service)

Detect, differentiate and diagnose: Identifying and managing ATTR-CM

Catch up with our panel of expert speakers from the BCS 2021 as they describe the clinical journey of a patient with ATTR-CM from detection through to diagnosis and management.

Prescribing information:
Aldactone (spironolactone) 25mg tablets
Aldactone (spironolactone) 50mg tablets
Aldactone (spironolactone) 100mg tablets

BSH 2020 - British Society for Heart Failure:

Dr Lisa Anderson (St George's Hospital, London)
Dr Robert Cooper (Liverpool Heart and Chest Hospital, Liverpool)

Future directions for management of cardiac amyloidosis

Dr Lisa Anderson provides an overview of the diagnosis and early management of cardiac amyloidosis and Dr Robert Cooper discusses the emerging treatment strategies.

PP-VYN-GBR-1139. January 2024
Learn about the current treatment option for ATTR-CM Treatment OptionLoading

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2024 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7866. January 2024
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-UNP-GBR-7812. January 2024

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​